glp 1 agonist in ckd GLP-1 receptor agonists' impact on cardio-renal outcomes and mortality T2D with acute kidney disease Study uncovers how chronic kidney

doi: 10.1159/000056191 142 KasemsukTVivithanapornPUnchernS

And then they did all the cosmetic stuff, Asprey told me

This stress is shown by the overexpression of iNOS, an enzyme primarily involved in the mitochondrial lipid peroxidation, with consequent damage of the cell membrane, which is validated by the accumulation of intracellular MDA: a hallmark of lipoperoxidation

Methodology Primary Research: Interviews with endocrinologists, clinical pharmacologists, and pharmaceutical market experts

But the money is actually going to made from medications that will radically change the treatment of specific and hard to treat diseases